Analysis of factors affecting therapeutic efficacy in intestinal inflammation

Analysis of factors affecting therapeutic efficacy in intestinal inflammation - Analysis of factors affecting therapeutic efficacy in intestinal inflammation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009697

Enrollment

Registered

2013-01-04

Start date

2012-12-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

endoscopic biopsy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are administrating or have a plan to administer biologics for the treatment of inflammatory bowel disease. 2. Patients who gave written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who are diagnosed as ileus. 2. Patients who receive anticoagulant and/or antiplatelet agents. 3. Patients whose platelet count was less than 50,000/microl. 4. Patients who are pregnant or suspected of being pregnant. 5. Patients who have psychiatric diseases. 6. Patients who are ineligible for this study as judged by the investigators.

Design outcomes

Primary

Measure	Time frame
Association of concentration of biological drugs in inflammatory/non-inflammatory mucosa with clincal parameters including laboratory data, clinical/endoscopic activity scores	—

Countries

Japan

Contacts

Public ContactShinichiro Shinzaki

Osaka University Graduate School of Medicine Gastroenterology and Hepatology

shinzaki@gh.med.osaka-u.ac.jp06-6879-3621

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026